Dr Angell reaffirms view that big pharma lacks innovation
This article was originally published in Scrip
Executive Summary
Dr Benjamin Zycher, one of the authors of a recent Manhattan Institute report debunking the idea that most drug innovation comes from publicly funded research (such as that from the US NIH) continues to be criticised by Dr Marcia Angell of Harvard University. The report was issued last month (Scrip No 3376, p 4).